Fundraising FoxCoLucid Pharmaceuticals
Durham, US · Delaware corporation · 4 known investors
Find your way into CoLucid Pharmaceuticals
Sign up to see every warm intro you have to CoLucid Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoLucid Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BK
Bernice KucaExecutive
MP
Mathers P. ThomasExecutive
NR
Nadia RupniakExecutive
TC
Timothy C. GuptonExecutive
Board
JI
RJ
Richard J. MarkhamBoard director
AM
Arthur M. PappasBoard director
ME
Martin EdwardsBoard director
LM
Investors · 4
Domain AssociatesreportedPrinceton · $200K – $15Mvia Jesse Treu · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
TVM CapitalinferredMunich · $1.1M – $16.2Mvia Luc Marengère · board
How we know: board seat on SEC Form D · Not right? Tell us
TVM Capital Life SciencereportedMontreal, Quebec
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$37.1M disclosed across 1 round · 2015
▶$37.1MraisedJan 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$37.1MraisedJan 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernice KucaExecutive Officer
- Mathers P. ThomasExecutive Officer, Director
- Jesse I. TreuDirector
- Nadia RupniakExecutive Officer
- Timothy C. GuptonExecutive Officer
- Richard J. MarkhamDirector
- Arthur M. PappasExecutive Officer, Director
- Martin EdwardsDirector
- Luc MarengereDirector
- Offering amount
- $37.1M
- Amount sold
- $37.1M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CoLucid Pharmaceuticals's investors?
- CoLucid Pharmaceuticals's investors include Pappas Capital, Domain Associates, TVM Capital, TVM Capital Life Science.
- How much funding has CoLucid Pharmaceuticals raised?
- CoLucid Pharmaceuticals has disclosed $37.1M raised across 1 round.
- Where is CoLucid Pharmaceuticals headquartered?
- CoLucid Pharmaceuticals is headquartered in Durham, US.